Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology, and Metabolism and National Institute for Health Research Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
J Clin Endocrinol Metab. 2018 Aug 1;103(8):3050-3059. doi: 10.1210/jc.2018-00529.
The 250-μg short Synacthen (corticotropin) test (SST) is the most commonly used tool to assess hypothalamo-pituitary-adrenal (HPA) axis function. There are many potentially reversible causes of adrenal insufficiency (AI), but no data to guide clinicians as to the frequency of repeat testing or likelihood of HPA axis recovery.
To use the SST results to predict adrenal recovery.
A retrospective analysis of 1912 SSTs data.
Seven hundred seventy-six patients with reversible causes of AI were identified who had at least two SSTs performed. A subgroup analysis was performed on individuals previously treated with suppressive doses of glucocorticoids (n = 110).
Recovery of HPA axis function.
SST 30-minute cortisol levels above or below 350 nmol/L (12.7 μg/dL) best predicted HPA axis recovery [area under the curve (AUC) receiver operating curve (ROC) = 0.85; median recovery time: 334 vs 1368 days, P = 8.5 × 10-13]: 99% of patients with a 30-minute cortisol >350 nmol/L recovered adrenal function within 4 years, compared with 49% in those with cortisol levels <350 nmol/L. In the subgroup analysis, delta cortisol (30-minute-basal) best predicted the recovery (AUC ROC = 0.77; median recovery time: 262 vs 974 days, P = 7.0 × 10-6). No patient with a delta cortisol <100 nmol (3.6 μg/dL) and a subsequent 1-year random cortisol <200 nmol/L (7.3 μg/dL) recovered HPA axis function.
Cortisol levels across an SST can be used to predict recovery of AI and may guide the frequency of repeat testing and inform both clinicians and patients as to the likelihood of restoration of HPA axis function.
250μg 短 Synacthen(促皮质素)试验(SST)是评估下丘脑-垂体-肾上腺(HPA)轴功能最常用的工具。肾上腺功能不全(AI)有许多潜在的可逆转原因,但没有数据指导临床医生重复测试的频率或 HPA 轴恢复的可能性。
使用 SST 结果预测肾上腺恢复情况。
对 1912 例 SST 数据进行回顾性分析。
确定了 776 例有可逆性 AI 病因的患者,他们至少进行了两次 SST。对先前接受糖皮质激素抑制剂量治疗的个体(n=110)进行了亚组分析。
HPA 轴功能恢复情况。
30 分钟皮质醇水平高于或低于 350 nmol/L(12.7μg/dL)最佳预测 HPA 轴恢复[曲线下面积(AUC)ROC 曲线=0.85;中位恢复时间:334 天与 1368 天,P=8.5×10-13]:30 分钟皮质醇>350 nmol/L 的患者 99%在 4 年内恢复了肾上腺功能,而皮质醇水平<350 nmol/L 的患者为 49%。在亚组分析中,皮质醇差值(30 分钟-基础值)最佳预测恢复情况(AUC ROC=0.77;中位恢复时间:262 天与 974 天,P=7.0×10-6)。无任何皮质醇差值<100 nmol(3.6μg/dL)且随后 1 年随机皮质醇<200 nmol/L(7.3μg/dL)的患者恢复 HPA 轴功能。
SST 期间的皮质醇水平可用于预测 AI 的恢复情况,并可指导重复测试的频率,为临床医生和患者提供 HPA 轴功能恢复的可能性信息。